Literature DB >> 335001

Immunization against retrograde pyelonephritis. III. Vaccination against chronic pyelonephritis due to Escherichia coli.

S J Brooks, J M Lyons, A I Braude.   

Abstract

Vaccination with formalin-treated cells of Escherichia coli serotype O6 protected against unilateral retrograde pyelonephritis due to E. coli O6 in rats with partial ureteral obstruction. This protection was manifested not only by less parenchymal destruction and shrinkage of the pyelonephritic left kidney, but also by less secondary pyelonephritis and compensatory hypertrophy in the opposite right kidney. Vaccinated rats eliminated E. coli from the kidney more rapidly, but even when infection persisted in the kidney, the chronic pyelonephritis was less severe in vaccinated rats. High levels of antibody to E. coli lipopolysaccharide were found in vaccinated animals and may have contributed to protection. These results raise the question of whether vaccination ought to be considered for patients predisposed to chronic bacterial pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 335001     DOI: 10.1093/infdis/136.5.633

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  [Immunopathology of pyelonephritis].

Authors:  K Rother
Journal:  Klin Wochenschr       Date:  1983-10-17

2.  Prevention of chronic experimental pyelonephritis by suppression of acute suppuration.

Authors:  M P Glauser; J M Lyons; A I Braude
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

3.  Protection by a polyvalent vaccine against challenge infection and pyelonephritis.

Authors:  D Kruze; K Biro; K Holzbecher; M Andrial; W Bossart
Journal:  Urol Res       Date:  1992

4.  Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring.

Authors:  P R Meylan; M Markert; J Bille; M P Glauser
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Prevention of acute and chronic ascending pyelonephritis in rats by aminoglycoside antibiotics accumulated and persistent in kidneys.

Authors:  J Bille; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

6.  Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis.

Authors:  P R Meylan; G Braoudakis; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

Review 7.  The inflammatory response and tissue damage. The example of renal scars following acute renal infection.

Authors:  M P Glauser; P Meylan; J Bille
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.